Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein

Overview of attention for article published in Frontiers in Bioengineering and Biotechnology, August 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 5,148 followers.

Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein https://t.co/MTiV5wBBoE https://t.co/G0NCKhqNkD

RT @FrontBioeng: New Research: Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein https://t.co/lirQPBjU7T #bioengi…

New Research: Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein https://t.co/lirQPBjU7T #bioengineering #biotech

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.